Eyewire interview of Bob Main - CEO Web Vision Technologies Discussing Vision for Mars Project November 2018 at American Academy of Ophthalmology Conference .
Had the honor of doing a podcast about my company and the work we are doing for NASA. Gives a good overview of our project to develop an all-in-one vision testing device for NASA to be used post-ISS for smaller spacecraft and deep space missions. We are also reaching out to the optical/ophthalmic community to help us with this important project. Fun stuff! they’ve been at it, and what got them to where they are.
Salt Lake City, Utah, October 16, 2018 - Web Vision Technologies is working closely with National Aeronautical Space Administration (NASA) to develop an “All-in-One” vision testing (diagnostic) device that can be deployed on spacecraft to do comprehensive vision testing, evaluation, and to guide medical interventions of astronauts experiencing vision problems on future long-duration, deep space missions. There is limited room for vision testing equipment on future spacecraft, so NASA needs a single device that is compact, space hardened, and can conduct a multitude of vision tests including retinal imaging, visual fields, functional vision, OCT, etc. Web Vision has adopted the name “Vision for Mars” and has received grant funding for Phase One from the Translational Research Institute for Space Health (TRISH), a NASA funded organization translating cutting edge emerging terrestrial biomedical research and technology development into applied space flight human risk mitigation strategies for human exploration missions.
The Problem - Astronauts currently experience significant vision issues on long duration space missions on the International Space Station (ISS). The issue is referred to by NASA as Spaceflight-Associated Neuro-ocular Syndrome or SANS. NASA anticipates that these vision issues will be exacerbated as astronauts travel to the Moon, Mars, asteroids and on other longer deep space missions. Currently, NASA is using existing off-the-shelf vision testing/diagnostic equipment on the ISS to diagnose and monitor the vision problems which are leading to loss of visual function such as swelling of the optic disc, globe flattening, choroidal folds, cotton wool spots and refractive shifts. However, as NASA sends astronauts to the Moon and beyond, this equipment will not withstand the rigors of space and most are too large to fit in future smaller spacecraft, which is smaller than the ISS. (See Figure 1). As a result, this Multifunctional Ophthalmic Device (MOD) diagnostic equipment has become critical and a high priority for NASA.
Collaborative Effort - Web Vision is seeking to partner with companies and individuals to be part of the Vision for Mars Project.
“We are excited to be launching the Vision for Mars Project to help NASA find a solution for a single device, multi-purpose vision testing equipment to be used on future spacecraft for deep space missions,” stated Bob Main, CEO Web Vision Technologies. “We are passionate about helping NASA achieve their goal of returning humans to the moon and traveling to Mars and beyond. In the next weeks we will be meeting with many executives from ophthalmic technology companies to find the right partner(s) to help us develop this important technology. We plan to finalize the selection of these partners in the first quarter of 2019.”
Related Links: To learn more about Web Vision Technologies and other NASA projects currently in development, visit www.WebVisionTechnologies.net
they’ve been at it, and what got them to where they are.
Web Vision Technologies Receives Grants to
Develop Vision Testing Devices for NASA
Allowing NASA to test and better understand the vision issues
affecting Astronauts on long duration flights
Salt Lake City, Utah, July 2018 - Web Vision Technologies (dba of Web Vision Centers Group, LLC) was recently awarded two grants from Translational Research Institute (TRISH) to develop vision testing devices for National Aeronautical Space Administration (NASA) to be used on the International Space Station (ISS). These devices will allow NASA scientists to detect, monitor progression, and guide medical interventions for vison issues astronauts are experiencing on long-duration deep space missions.
Background information - For years now, scientists have known that the human body suffers in the microgravity environment of space. The term “Spaceflight-Associated Neuro-ocular Syndrome” (SANS) has been adopted to describe the neuro-ocular responses to long-duration spaceflight. Although the causes of ocular functional and anatomical changes in astronauts of long-duration spaceflights remain largely unknown, recent studies by NASA are gathering new data.
SANS, known for causing significant vision issues in a substantial number of astronauts returning from long duration space flight, is also suspected as the main cause of the physical changes taking place in the interior of the eyes of these same astronauts. NASA views the SANS issue as a significant problem and needs to be further studied/understood and a solution needs to be found before sending astronauts on deep space exploration missions. Substantial efforts are being made to investigate countermeasures to preserve the eye health of crew members.
Currently several ocular/vision tests are performed onboard the ISS with conventional vision testing devices. However, the equipment was not designed for the rigors of spaceflight and are subject to breaking down due to radiation and most devices are currently too large to be used on smaller spacecraft that will be used for deep space missions.
Vision Technology Web Vision Technologies is developing - To help find solutions to these issues, NASA has asked Web Vision to develop two different specialized vision testing devices:
Both technologies will provide NASA scientists with the information they need to detect, monitor SANS progression, and guide medical interventions for astronauts while still in space.
Grant Funding by TRISH - NASA’s Human Research Program (HRP) partners with external entities in researching and developing innovative approaches to reduce risks to humans on long-duration exploration missions, including NASA’s Journey to Mars. One of these partnerships is the Translational Research Institute for Space Health (TRISH). The mission of the TRISH is to lead a national effort in translating cutting edge emerging terrestrial biomedical research and technology development into applied space flight human risk mitigation strategies for human exploration missions. The funds for the Web Vision grants are provided by TRISH
Web Vision is partnering with Nidek Technologies, a global leader in vision care instrumentation for the eye care industry, to help with the development, design, and prototyping of the two devices. “We are excited to be working with Web Vision on these NASA projects. We have a wealth of experience in design and development of vision testing/diagnostic equipment and are looking forward to the challenge, especially given the demanding NASA specifications”; Cesare Tanassi -Managing Director of NIDEK TECHNOLOGIES SRL
Web Vision plans to commercialize these and other vison care technologies in the near future. The company reports that they are currently finalizing their market strategy and raising funds for the launch.
“We are excited to be working with NASA on these two very important vision testing devices,” states Bob Main, CEO Web Vision Technologies. “We are passionate about helping the space program achieve their goal of returning to the moon and putting humans on Mars and we are confident that the team we have put together will be able to deliver the technology that NASA needs to help monitor and find a solution to the SANS vision issue affecting astronauts on long duration flights. We are also grateful to TRISH for supplying the funding necessary to develop this technology and many more in the future.”
Dorit Donoviel, Ph.D, Director of TRISH said, “Our thanks to Web Vision for taking on the challenge of developing these technologies. We have worked with Web Vision in the past on other TRISH funded projects and they have proven to be a dedicated and talented group that can deliver the vision care technologies NASA needs. It is our core mission to help companies like Web Vision get the funding and support they need to help NASA get the technology they need to go to Mars”.
To arrange an interview with Bob Main, President & CEO of Web Vision Technologies please email him directly at: email@example.com .
To learn more about Web Vision Technologies or the projects currently in development, visit www.WebVisionTechnologies.net.
Web Vision Technologies (Web Vision) is a wholly owned dba of Web Vision Centers Group, LLC, based in the Salt Lake City Utah area, and is a digital vision care technology company. Web Vision has been in business since 2010 and is currently developing several vison testing devices for NASA, funded by grants from Translational Research Institute (TRISH). Additionally, they also consultant for several global vision care companies, helping them develop and bring vision care technologies to market. Bob Main, MS Ophthalmic Optics, is CEO of Web Vision and is an optical industry veteran of over 35 years. Web Vision is currently raising funds to commercialize similar technology they are developing for NASA.
Nidek Technologies - Nidek Technologies, Srl (NT) is a wholly owned Italian subsidiary of Nidek Co, Ltd, Gamagori, Japan (NCO). NCO is one of the world’s largest; most respected producers of ophthalmic instruments and has been in business since 1971. NT has been their subsidiary for 20 years. NT has evolved into and ophthalmic device design/manufacturing center for NCO; developing, Confocal Microscopes, Retinal Cameras, Corneal Topographers, Micro Perimeters and other instruments with their associated software. In addition, NT created EMR software over 15 years ago and has constantly developed it since. Their latest iteration, nLife, is cloud based now delivered in large clinics in the Italian market.
NASA’s Human Research Program (HRP) partners with external entities in researching and developing innovative approaches to reduce risks to humans on long-duration exploration missions, including NASA’s Journey to Mars. One of these partnerships is the Translational Research Institute for Space Health (TRISH) , a cooperative agreement with a consortium led by Baylor College of Medicine and includes the California Institute of Technology in Pasadena and Massachusetts Institute of Technology in Cambridge. The mission of the TRISH is to lead a national effort in translating cutting edge emerging terrestrial biomedical research and technology development into applied space flight human risk mitigation strategies for human exploration missions.
Additional related graphics available at http://bit.ly/WebVisionPressReleaseInfo